Pérez-Cruz Carla, Cañas María-Alexandra, Giménez Rosa, Badia Josefa, Mercade Elena, Baldomà Laura, Aguilera Laura
Secció de Microbiologia, Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain.
Secció de Bioquímica i Biologia Molecular, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain.
PLoS One. 2016 Dec 30;11(12):e0169186. doi: 10.1371/journal.pone.0169186. eCollection 2016.
Membrane vesicles (MVs) produced by Gram-negative bacteria are being explored for novel clinical applications due to their ability to deliver active molecules to distant host cells, where they can exert immunomodulatory properties. MVs released by the probiotic Escherichia coli Nissle 1917 (EcN) are good candidates for testing such applications. However, a drawback for such studies is the low level of MV isolation from in vitro culture supernatants, which may be overcome by the use of mutants in cell envelope proteins that yield a hypervesiculation phenotype. Here, we confirm that a tolR mutation in EcN increases MV production, as determined by protein, LPS and fluorescent lipid measurements. Transmission electron microscopy (TEM) of negatively stained MVs did not reveal significant differences with wild type EcN MVs. Conversely, TEM observation after high-pressure freezing followed by freeze substitution of bacterial samples, together with cryo-TEM observation of plunge-frozen hydrated isolated MVs showed considerable structural heterogeneity in the EcN tolR samples. In addition to common one-bilayer vesicles (OMVs) and the recently described double-bilayer vesicles (O-IMVs), other types of MVs were observed. Time-course experiments of MV uptake in Caco-2 cells using rhodamine- and DiO-labelled MVs evidenced that EcN tolR MVs displayed reduced internalization levels compared to the wild-type MVs. The low number of intracellular MVs was due to a lower cell binding capacity of the tolR-derived MVs, rather than a different entry pathway or mechanism. These findings indicate that heterogeneity of MVs from tolR mutants may have a major impact on vesicle functionality, and point to the need for conducting a detailed structural analysis when MVs from hypervesiculating mutants are to be used for biotechnological applications.
革兰氏阴性菌产生的膜泡(MVs)因其能够将活性分子传递到远处的宿主细胞并在其中发挥免疫调节特性,正被探索用于新型临床应用。益生菌大肠杆菌Nissle 1917(EcN)释放的MVs是测试此类应用的良好候选者。然而,此类研究的一个缺点是从体外培养上清液中分离MVs的水平较低,这可以通过使用细胞包膜蛋白突变体来克服,这些突变体可产生高泡化表型。在此,我们证实EcN中的tolR突变会增加MV的产生,这通过蛋白质、脂多糖和荧光脂质测量得以确定。对负染MVs的透射电子显微镜(TEM)观察未发现与野生型EcN MVs有显著差异。相反,对细菌样品进行高压冷冻后再进行冷冻置换后的TEM观察,以及对骤冷冷冻的水合分离MVs的冷冻TEM观察显示,EcN tolR样品中存在相当大的结构异质性。除了常见的单层膜泡(OMVs)和最近描述的双层膜泡(O - IMVs)外,还观察到了其他类型的MVs。使用罗丹明和DiO标记的MVs对Caco - 2细胞摄取MVs的时间进程实验证明,与野生型MVs相比,EcN tolR MVs的内化水平降低。细胞内MVs数量较少是由于tolR衍生的MVs与细胞的结合能力较低,而非不同的进入途径或机制。这些发现表明,tolR突变体产生的MVs的异质性可能对囊泡功能有重大影响,并指出当高泡化突变体产生的MVs用于生物技术应用时,需要进行详细的结构分析。